Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
17-3
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Journals
Journal #460
advertisement
Ocular Immunology and Inflammation
17
Showing records 1 to 17 |
Display all abstracts in
Ocular Immunology and Inflammation
66525
Changes in Inflammatory Activity after Glaucoma Filtration Surgery in Children with Chronic Anterior Uveitis
Wiese C
Ocular Immunology and Inflammation
2016; 0: 1-5
66368
Proinflammatory Cytokines Induce XFG Development
Sarenac Vulovic TS
Ocular Immunology and Inflammation
2015; 0: 1-7
66378
Prediction of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma by Using Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio
Ozgonul C
Ocular Immunology and Inflammation
2015; 0: 1-6
66536
Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis
Takeuchi M
Ocular Immunology and Inflammation
2016; 0: 1-6
66378
Prediction of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma by Using Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio
Sertoglu E
Ocular Immunology and Inflammation
2015; 0: 1-6
66525
Changes in Inflammatory Activity after Glaucoma Filtration Surgery in Children with Chronic Anterior Uveitis
Heiligenhaus A
Ocular Immunology and Inflammation
2016; 0: 1-5
66536
Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis
Kanda T
Ocular Immunology and Inflammation
2016; 0: 1-6
66368
Proinflammatory Cytokines Induce XFG Development
Pavlovic SM
Ocular Immunology and Inflammation
2015; 0: 1-7
66378
Prediction of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma by Using Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio
Mumcuoglu T
Ocular Immunology and Inflammation
2015; 0: 1-6
66536
Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis
Taguchi M
Ocular Immunology and Inflammation
2016; 0: 1-6
66368
Proinflammatory Cytokines Induce XFG Development
Zdravkovic NS
Ocular Immunology and Inflammation
2015; 0: 1-7
66525
Changes in Inflammatory Activity after Glaucoma Filtration Surgery in Children with Chronic Anterior Uveitis
Heinz C
Ocular Immunology and Inflammation
2016; 0: 1-5
66536
Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis
Shibata M
Ocular Immunology and Inflammation
2016; 0: 1-6
66378
Prediction of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma by Using Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio
Ozge G
Ocular Immunology and Inflammation
2015; 0: 1-6
66536
Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis
Mine I
Ocular Immunology and Inflammation
2016; 0: 1-6
66378
Prediction of Pseudoexfoliation Syndrome and Pseudoexfoliation Glaucoma by Using Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio
Gokce G
Ocular Immunology and Inflammation
2015; 0: 1-6
66536
Evaluation of Efficacy and Safety of Latanoprost/Timolol versus Travoprost/Timolol Fixed Combinations for Ocular Hypertension Associated with Uveitis
Sakurai Y
Ocular Immunology and Inflammation
2016; 0: 1-6
Issue
17-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement